Press release: hart-scott-rodino waiting period expires for sanofi's acquisition of provention bio, inc.

Hart-scott- rodino waiting period expires for sanofi's acquisition of provention bio, inc. paris, france – april 26 , 2023 – sanofi announced today that the waiting period under the hart-scott-rodino antitrust improvements act of 1976, as amended (the “hsr act”), applicable to sanofi's proposed acquisition of provention bio, inc. (“provention bio”, nasdaq: prvb) has expired. on march 24, 2023, sanofi commenced a cash tender offer (the “offer”) to purchase all outstanding shares of common stock of provention bio (the “shares”), for $25.00 per share, to the seller thereof in cash, without interest and subject to any withholding taxes required by applicable law.
PRVB Ratings Summary
PRVB Quant Ranking